• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>PIMCO Municipal Income II

PIMCO Municipal Income II

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Neurology Times Advances Multiple Sclerosis Education

    Neurology Times Advances Multiple Sclerosis Education

  2. Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA® (ibrutinib) Phase III Combination HELIOS Trial Based on Interim Analysis Showing Significant Improvement in ...

    Independent Data Monitoring Committee Unanimously Recommends Unblinding of IMBRUVICA® (ibrutinib) Phase III Combination HELIOS Trial Based on Interim Analysis Showing Significant Improvement in Progression-Free Survival in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  3. A Closer Look at CEF Duration Risk

    An examination of 10 CEFs with the highest duration risk.

  4. Year in Review: Municipal CEFs

    We take a look at 2012's municipal CEF performance, distribution cuts, mergers, and more.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.